On Dec.2,2014, our vice president Liangjian accompanied some domestic executives to visit Cipla, which is the second largest pharmaceutical factory in India. Cipla is international and has a good reputation in the field of generic drug. For the moment, some Chinese enterprises has been their stable suppliers. On Dec.3 and Dec.4, they visited UBM Live, organizer of the exhibition and Indian Pharmexcil. During the visit, China and India had a heated discussion about the cooperation on API, preparations and generic drug and the development of economy and trade of pharmacy. Under the effort of pharmaceutical profession association, the two sides strengthed the knowledge of each other, deepened mutual cooperation and brodened their business.